Company: BIAF
Filing Date: 2025-09-24
Form Type: S-1
Source: 0001493152-25-014730
Chunk: 2

Company: bioAffinity Technologies, Inc.
Filing Date: 2025-09-24
Form: S-1
Chunk 2
---
927 Pre-Funded Warrants to Purchase Shares of Common Stock

Placement Agent Warrants to Purchase up to 21,898 Shares of Common Stock

Up to 1,846,716 Shares of Common Stock Underlying the Common Stock Purchase Warrants,

Pre-Funded Warrants and Placement Agent Warrants</div>

We are offering up to 729,927 shares of our Common Stock, $0.007 par value per share (the “Common Stock”), together with common stock purchase warrants to purchase up to 1,094,891 shares of Common Stock (the “September 2025 Warrants”). Each share of our Common Stock, or a Pre-Funded Warrant in lieu thereof (as described below), is being sold together with one September 2025 Warrant to purchase one share of Common Stock. The shares of Common Stock and September 2025 Warrants are immediately separable and will be issued separately in this offering, but must be purchased together in this offering. The assumed public offering price for each share of Common Stock and accompanying September 2025 Warrant is $5.48, which was the closing price of our Common Stock on The Nasdaq Capital Market (“Nasdaq”) on September 17, 2025, as adjusted for the 1-for-30 reverse stock split described below. The September 2025 Warrants will have an exercise price per share of $5.48, will be exercisable beginning on the effective date of shareholder approval of the issuance of the shares upon exercise of the September 2025 Warrants (“Warrant Shareholder Approval”), provided, however, if the Pricing Conditions (as defined below) are met, the warrants will be exercisable upon issuance (the “Initial Exercise Date”) and will expire on the five-year anniversary of the Initial Exercise Date. As used herein, “Pricing Conditions” means that the combined offering price per share and accompanying September 2025 Warrant is such that the Warrant Shareholder Approval is not required under the rules of the Nasdaq Stock Market LLC (“Nasdaq”) because either (i) the offering is an at-the-market offering under Nasdaq rules and such price equals or exceeds the sum of (a) the applicable “Minimum Price” per share under Nasdaq Rule 5635(d) plus (b) $0.125 per whole share of Common Stock underlying the September 2025 Warrants or (ii) the offering is a discounted offering where the pricing and discount (including attributing a value of $0